Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells.
about
Salmonella induced IL-23 and IL-1beta allow for IL-12 production by monocytes and Mphi1 through induction of IFN-gamma in CD56 NK/NK-like T cellsThe transcription factor MafB antagonizes antiviral responses by blocking recruitment of coactivators to the transcription factor IRF3Dendritic-Tumor Fusion Cell-Based Cancer VaccinesAdjuvants: Classification, Modus Operandi, and LicensingInduction of CD4(+) Regulatory and Polarized Effector/helper T Cells by Dendritic CellsPathogen-Associated Molecular Patterns Induced Crosstalk between Dendritic Cells, T Helper Cells, and Natural Killer Helper Cells Can Improve Dendritic Cell VaccinationImmunity to Pathogens Taught by Specialized Human Dendritic Cell SubsetsNanoparticle Drug Delivery Systems Designed to Improve Cancer Vaccines and ImmunotherapyStructure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery systemTLR cross-talk confers specificity to innate immunityTargeting toll-like receptors: promising therapeutic strategies for the management of sepsis-associated pathology and infectious diseasesDendritic cell-based immunotherapy for glioma: multiple regimens and implications in clinical trialsTLR8: the forgotten relative revindicatedNotch ligand delta-like 4-pretreated dendritic cells alleviate allergic airway responses by enhancing IL-10 productionTLR4 and TLR7/8 Adjuvant Combinations Generate Different Vaccine Antigen-Specific Immune Outcomes in Minipigs when Administered via the ID or IN RoutesDendritic Cell Function during Chronic Hepatitis C Virus and Human Immunodeficiency Virus Type 1 InfectionToll-like Receptor 7 Mitigates Lethal West Nile Encephalitis via Interleukin 23-Dependent Immune Cell Infiltration and HomingSynthetic Nanoparticles for Vaccines and ImmunotherapyDendritic Cell-Based Immunotherapy Treatment for Glioblastoma MultiformeTLR ligands up-regulate Trex1 expression in murine conventional dendritic cells through type I Interferon and NF-κB-dependent signaling pathwaysTLR4 signaling in effector CD4+ T cells regulates TCR activation and experimental colitis in miceSynergistic effect between amoxicillin and TLR ligands on dendritic cells from amoxicillin-delayed allergic patientsFrailty in old age is associated with decreased interleukin-12/23 production in response to toll-like receptor ligationSrc kinases are required for a balanced production of IL-12/IL-23 in human dendritic cells activated by Toll-like receptor agonistsEnvironmental biodiversity, human microbiota, and allergy are interrelatedDNA-Encoded Flagellin Activates Toll-Like Receptor 5 (TLR5), Nod-like Receptor Family CARD Domain-Containing Protein 4 (NRLC4), and Acts as an Epidermal, Systemic, and Mucosal-AdjuvantA randomized pilot trial testing the safety and immunologic effects of a MAGE-A3 protein plus AS15 immunostimulant administered into muscle or into dermal/subcutaneous sites.Programming the magnitude and persistence of antibody responses with innate immunity.Signaling network of dendritic cells in response to pathogens: a community-input supported knowledgebaseToll-like receptor expression and responsiveness of distinct murine splenic and mucosal B-cell subsets.A library of gene expression signatures to illuminate normal and pathological lymphoid biology.Host-pathogen interactions: a biological rendez-vous of the infectious nonself and danger models?Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands.Nanoparticle-delivered multimeric soluble CD40L DNA combined with Toll-Like Receptor agonists as a treatment for melanoma.Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice.Parasite-derived plasma microparticles contribute significantly to malaria infection-induced inflammation through potent macrophage stimulationCyclophosphamide induces bone marrow to yield higher numbers of precursor dendritic cells in vitro capable of functional antigen presentation to T cells in vivo.Trypanosomiasis-induced Th17-like immune responses in carp.Advances in the design and delivery of peptide subunit vaccines with a focus on toll-like receptor agonistsLack of Association Between Toll-like Receptor 2 Polymorphisms (R753Q and A-16934T) and Atopic Dermatitis in Children from Thrace Region of Turkey
P2860
Q24293096-7EFD7A6E-2036-456E-AD46-FD3E1FE66505Q24336528-17DF7021-6D98-476C-94F8-0A7670DB42A0Q26744827-5EAE3F03-289C-4C7C-B50B-209A6FC0099AQ26747586-80BC696C-83D5-4A82-B8BC-48800FEE713BQ26764866-B931415D-FB85-4908-959B-708CFD299F5BQ26765345-15E62B3D-7E60-4EA4-BDDF-BA657D85CF4AQ26777195-1285D04B-B95B-4B90-9A21-9325BCB3FE7FQ26782566-16485588-E3D7-46C3-98A5-455FFF868D9FQ27004381-363CF5AC-EAD9-4058-BFD4-6829761E4542Q27008875-96E089A8-8375-43E6-83FD-E3B37B202E72Q27010345-2F8C1015-1CC1-46D3-8483-210037F8BC7DQ27014829-C81F2450-A77E-475F-9FB2-A0354B53EFB0Q27026056-C5EC2070-8C8B-4EA0-89BB-02AAEA4A27E9Q27320168-2CEA37C4-977E-487D-A9FE-22C3C205B0CCQ27322386-E49C622D-4A18-4F26-8DB7-DF089F62F6FFQ27481412-7B7DACCC-EAC8-4278-A4C4-3FCE3FAD3893Q27488876-3E50A901-E65B-489E-A99C-0FEA6E1C4003Q28085375-9FB851F2-616E-4A70-B17D-4CED992EF42BQ28087485-8BA6A41B-E99E-4154-90A3-B1AD6874F888Q28510527-DDB6D3E5-1E3D-4948-B314-D7F9827C8BF2Q28513789-2C5A0FAB-A946-49F7-BDAF-1B2CF53EBD73Q28533519-3CB90B90-DD86-4DA4-B5EB-A736B5FA2081Q28533634-A828591D-E1B6-47B1-ACA1-1D44128C4A0EQ28750407-15BBF4F0-27EE-4D17-A68D-711DD88179F6Q30052290-FE1526B0-078D-4448-B3FA-36991CF6C8FAQ30223578-AAC31E30-99AF-42FD-AFBB-EDB28D6F59A5Q30278070-7FCCEF35-B926-48F3-A145-E986DEFE4AECQ30400144-0BF7E39C-2E7D-4117-9ED7-85BA63545344Q30484693-B5B0C54B-4DF7-4D8E-A72D-97D6513D4518Q30834266-3E4C3623-A6BE-468E-AF38-89E73C16C463Q33240316-1A3F90D2-A9DC-42C4-AA31-E9C9C818434AQ33245068-0D27EBAA-D7D5-4CE9-B7D9-314D2ACB307AQ33489847-00A472ED-E669-46B4-8D4C-106A8F6DF915Q33509292-AC68C0AB-9981-4F06-AE5B-BBA1AECE0C40Q33609436-8D142561-0B49-4626-9640-0F2E71A1EEDAQ33618034-AE7248F4-695C-4ADE-BA2E-A1E750C73D53Q33653210-92491199-ABE9-43EA-9B9D-D9575607CFA5Q33707467-22409100-406C-4697-AE5C-57DE7F6A546DQ33721641-44C3DC51-616E-4519-A09B-1E05804A1B61Q33745268-B6B4715F-42D0-43E2-BB92-D16C8C6FA7D0
P2860
Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 July 2005
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Selected Toll-like receptor ag ...... ng program in dendritic cells.
@en
Selected Toll-like receptor ag ...... ng program in dendritic cells.
@nl
type
label
Selected Toll-like receptor ag ...... ng program in dendritic cells.
@en
Selected Toll-like receptor ag ...... ng program in dendritic cells.
@nl
prefLabel
Selected Toll-like receptor ag ...... ng program in dendritic cells.
@en
Selected Toll-like receptor ag ...... ng program in dendritic cells.
@nl
P2093
P2860
P356
P1433
P1476
Selected Toll-like receptor ag ...... ng program in dendritic cells.
@en
P2093
Andrea Rinaldi
Francesco Bertoni
Giorgio Napolitani
P2860
P304
P356
10.1038/NI1223
P407
P577
2005-07-03T00:00:00Z